Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5647 USD | -5.91% | +17.65% | +106.85% |
Mar. 28 | North American Morning Briefing : Stocks Set for -2- | DJ |
Feb. 23 | BrainStorm Cell Therapeutics Submits Special Protocol Assessment Request to FDA for Phase 3b Trial of NurOwn in ALS | CI |
- Stock
- Equities
- Stock Brainstorm Cell Therapeutics Inc. - Nasdaq
- News Brainstorm Cell Therapeutics Inc.